Histopathologic effects of soluble glucan and WR-2721, independently and combined in C3H/HeN mice.
Soluble glucan, an immunomodulator, and Walter Reed (WR)-2721, a radioprotectant, increase postirradiation survival when administered before and after exposure, respectively. Combined, these agents act synergistically through WR-2721's ability to spare hematopoietic stem/progenitor cells from radiation injury and glucan's ability to subsequently stimulate spared cells to proliferate. In this study, the histopathologic effects of WR-2721 (200 mg/kg, ip) and glucan (250 mg/kg, iv), at doses capable of increasing survival in lethally irradiated mice, were evaluated in unirradiated and irradiated female C3H/HeN mice. After treatment, whole body weights and wet organ weights of liver, spleen, and kidney, as well as gross and histologic changes in these and other tissues, were monitored on Days 1, 4, 7, 11, 15, 21, and 28. Morphometric studies of splenic white and red pulps were also performed. Soluble glucan, with or without WR-2721, in unirradiated groups, was associated with splenomegaly, transient morphometrically determined perturbations of white and red pulp areas, and histologic alterations of white pulp. In irradiated mice, splenic weight loss was initially dampened in glucan groups and accompanied by morphologic and histologic changes similar to those seen in unirradiated counterparts. The subsequent rebound of splenic parameters in irradiated mice was limited to WR-2721-treated mice and was associated with hematopoietic reconstitution. Glucan, with or without WR-2721, in unirradiated groups was associated with transient hepatomegaly and associated histologic changes. Similar changes in irradiated animals were seen only in the combined treatment group.
Baker
W H
WH
Armed Forces Radiobiology Research Institute, Bethesda, Maryland 20889-5145.
Nold
J B
JB
Patchen
M L
ML
Jackson
W E
WE
D004999:Amifostine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects / Q000528:radiation effects; D004357:Drug Synergism; D005260:Female; D005936:Glucans / Q000008:administration & dosage / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000528:radiation effects; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D008099:Liver / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D051379:Mice; D008809:Mice, Inbred C3H; D009336:Necrosis; D009929:Organ Size / Q000187:drug effects / Q000528:radiation effects; D013154:Spleen / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D014916:Whole-Body Irradiation
D005936:Glucans; D004999:Amifostine